Novel Gene Therapy for Vision Loss Experiment to Fly to ISS
Will Research Treatments for Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is a leading cause of blindness in older adults, affecting more than 200 million people globally. Patients in the intermediate stage of the disease currently lack an effective treatment to improve vision or slow disease progression. Now, a new gene therapy from biotech innovator Oculogenex, Inc. may change that nar…
Keep reading with a 7-day free trial
Subscribe to The Journal of Space Commerce to keep reading this post and get 7 days of free access to the full post archives.